Characterizing intra-tumor regions on quantitative ultrasound parametric images to predict breast cancer response to chemotherapy at pre-treatment

被引:16
|
作者
Taleghamar, Hamidreza [1 ]
Moghadas-Dastjerdi, Hadi [2 ,3 ,4 ]
Czarnota, Gregory J. [2 ,3 ,4 ]
Sadeghi-Naini, Ali [1 ,2 ,3 ,4 ]
机构
[1] York Univ, Lassonde Sch Engn, Dept Elect Engn & Comp Sci, Toronto, ON, Canada
[2] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada
[3] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Phys Sci Platform, Toronto, ON, Canada
[4] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Dept Radiat Oncol, Toronto, ON, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
PATHOLOGICAL COMPLETE RESPONSE; BACKSCATTER COEFFICIENT MEASUREMENTS; POSITRON-EMISSION-TOMOGRAPHY; NEOADJUVANT CHEMOTHERAPY; THERAPY RESPONSE; WOMEN; BIOMARKERS; MODEL;
D O I
10.1038/s41598-021-94004-y
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The efficacy of quantitative ultrasound (QUS) multi-parametric imaging in conjunction with unsupervised classification algorithms was investigated for the first time in characterizing intra-tumor regions to predict breast tumor response to chemotherapy before the start of treatment. QUS multi-parametric images of breast tumors were generated using the ultrasound radiofrequency data acquired from 181 patients diagnosed with locally advanced breast cancer and planned for neo-adjuvant chemotherapy followed by surgery. A hidden Markov random field (HMRF) expectation maximization (EM) algorithm was applied to identify distinct intra-tumor regions on QUS multi-parametric images. Several features were extracted from the segmented intra-tumor regions and tumor margin on different parametric images. A multi-step feature selection procedure was applied to construct a QUS biomarker consisting of four features for response prediction. Evaluation results on an independent test set indicated that the developed biomarker coupled with a decision tree model with adaptive boosting (AdaBoost) as the classifier could predict the treatment response of patient at pre-treatment with an accuracy of 85.4% and an area under the receiver operating characteristic (ROC) curve (AUC) of 0.89. In comparison, the biomarkers consisted of the features derived from the entire tumor core (without consideration of the intra-tumor regions), and the entire tumor core and the tumor margin could predict the treatment response of patients with an accuracy of 74.5% and 76.4%, and an AUC of 0.79 and 0.76, respectively. Standard clinical features could predict the therapy response with an accuracy of 69.1% and an AUC of 0.6. Long-term survival analyses indicated that the patients predicted by the developed model as responders had a significantly better survival compared to the non-responders. Similar findings were observed for the two response cohorts identified at post-treatment based on standard clinical and pathological criteria. The results obtained in this study demonstrated the potential of QUS multi-parametric imaging integrated with unsupervised learning methods in identifying distinct intra-tumor regions in breast cancer to characterize its responsiveness to chemotherapy prior to the start of treatment.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Quantitative Ultrasound Evaluation of Tumor Cell Death Response in Locally Advanced Breast Cancer Patients Receiving Chemotherapy
    Sadeghi-Naini, Ali
    Papanicolau, Naum
    Falou, Omar
    Zubovits, Judit
    Dent, Rebecca
    Verma, Sunil
    Trudeau, Maureen
    Boileau, Jean Francois
    Spayne, Jacqueline
    Iradji, Sara
    Sofroni, Ervis
    Lee, Justin
    Lemon-Wong, Sharon
    Yaffe, Martin
    Kolios, Michael C.
    Czarnota, Gregory J.
    CLINICAL CANCER RESEARCH, 2013, 19 (08) : 2163 - 2174
  • [32] Use of Tumor-infiltrating lymphocytes (TILs) to predict the treatment response to eribulin chemotherapy in breast cancer
    Kashiwagi, Shinichiro
    Asano, Yuka
    Goto, Wataru
    Takada, Koji
    Takahashi, Katsuyuki
    Noda, Satoru
    Takashima, Tsutomu
    Onoda, Naoyoshi
    Tomita, Shuhei
    Ohsawa, Masahiko
    Hirakawa, Kosei
    Ohira, Masaichi
    PLOS ONE, 2017, 12 (02):
  • [33] Quantitative Image Features Extracted From Pre-Treatment Magnetic Resonance Images Predict Post-Chemoradiation Response for Patients with Local Advanced Rectal Cancer
    Pan, X.
    Li, N.
    Qi, X.
    MEDICAL PHYSICS, 2018, 45 (06) : E680 - E680
  • [34] On-treatment biopsies to predict response to neoadjuvant chemotherapy for breast cancer
    Sinn, Bruno Valentin
    Sychra, Katharina
    Untch, Michael
    Karn, Thomas
    van Mackelenbergh, Marion
    Huober, Jens
    Schmitt, Wolfgang
    Marme, Frederik
    Schem, Christian
    Solbach, Christine
    Stickeler, Elmar
    Tesch, Hans
    Fasching, Peter A.
    Schneeweiss, Andreas
    Mueller, Volkmar
    Holtschmidt, Johannes
    Nekljudova, Valentina
    Loibl, Sibylle
    Denkert, Carsten
    BREAST CANCER RESEARCH, 2024, 26 (01)
  • [35] Quantitative Ultrasound Spectral Parametric Maps: Early Surrogates of Cancer Treatment Response
    Sadeghi-Naini, Ali
    Falou, Omar
    Czarnota, Gregory J.
    2012 ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC), 2012, : 2672 - 2675
  • [36] Unveiling the impact of intra-tumor heterogeneity on treatment response to achieve precision medicine for endometrial cancer patients
    Villafranca-Magdalena, Beatriz
    Moiola, Cristian Pablo
    Charles, Olga
    Denizli, Melek
    Rebull, Marta
    Parra, Genis
    Castellvi, Josep
    Bebia, Vicente
    Cabrera, Silvia
    Gil-Moreno, Antonio
    Colas, Eva
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A512 - A512
  • [37] Chemotherapy-Response Monitoring of Breast Cancer Patients Using Quantitative Ultrasound-Based Intra-Tumour Heterogeneities
    Ali Sadeghi-Naini
    Lakshmanan Sannachi
    Hadi Tadayyon
    William T. Tran
    Elzbieta Slodkowska
    Maureen Trudeau
    Sonal Gandhi
    Kathleen Pritchard
    Michael C. Kolios
    Gregory J. Czarnota
    Scientific Reports, 7
  • [38] Chemotherapy-Response Monitoring of Breast Cancer Patients Using Quantitative Ultrasound-Based Intra-Tumour Heterogeneities
    Sadeghi-Naini, Ali
    Sannachi, Lakshmanan
    Tadayyon, Hadi
    Tran, William T.
    Slodkowska, Elzbieta
    Trudeau, Maureen
    Gandhi, Sonal
    Pritchard, Kathleen
    Kolios, Michael C.
    Czarnota, Gregory J.
    SCIENTIFIC REPORTS, 2017, 7
  • [39] Does Pre-treatment Metabolic Tumor Growth Rate (MTGR) Predict Progression in Lung Cancer?
    Eastham, D. V.
    Chapman, C. H.
    Rao, A. K.
    Narasimhan, B.
    Quon, A.
    Vasanawala, M. S.
    Wakelee, H.
    Le, Q.
    Colevas, A. D.
    Loo, B. W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S446 - S446
  • [40] Pre-treatment Near-Infrared Spectral Tomography (NIRST) to predict pathologic complete response to neoadjuvant chemotherapy (NAC) in women with locally advanced breast cancer (LABC)
    Kaufman, Peter
    Jiang, Shudong
    diFlorio-Alexander, Roberta
    Gui, Jiang
    Pogue, Brian W.
    Paulsen, Keith D.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)